Brenton Flatt

Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)

Brenton Flatt, Richard Martin, Tielin Wang et al. · Journal of Medicinal Chemistry · 2009 · 161 citations · Full text

Chronic Administration, Molecular Biology, Farnesoid X Receptor +19

Synthesis, Structure, and Reactivity of a Rhenium Oxo-Vinylalkylidene Complex

Brenton Flatt, Robert H. Grubbs, Rusty L. Blanski et al. · Organometallics · 1994 · 51 citations

Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ

Ellen K. Kick, Richard Martin, Yinong Xie et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 41 citations · Full text

Molecular Pharmacology, Drug Target, Biochemistry +7

Syntheses of 2,4‐diaryl‐2,3‐dihydro‐1,5‐benzothiazepines

Alan R. Katritzky, Boris V. Rogovoy, Christophe Chassaing et al. · Journal of Heterocyclic Chemistry · 2000 · 22 citations

Substituted O ‐Aminothiophenols, Natural Sciences, Medicine +11

Syntheses of 2-Alkylamino- and 2-Dialkylamino-4,6-diarylpyridines and 2,4,6-Trisubstituted Pyrimidines Using Solid-Phase-Bound Chalcones

Alan R. Katritzky, L.S. Serdyuk, Christophe Chassaing et al. · Journal of Combinatorial Chemistry · 2000 · 20 citations

Modified Mitsunobu Protocol, Combinatorial Chemistry, Engineering +11